Alegro appoints Paul Godard as Chief Financial Officer



    TORONTO, June 2 /CNW/ - Alegro Health Corp. ("Alegro") (TSX-V: AGO), a
provider of medical, surgical and disability management services, announced
today that it has appointed Paul Godard to the position of Chief Financial
Officer.
    "Paul brings extensive financial and management experience to our team,"
said Brenda Rasmussen, President and Chief Executive Officer of Alegro. "With
his exceptional knowledge of the public/private healthcare industry in
Ontario, Paul adds an insight that will play a key role in our growth
strategy."
    Mr. Godard joins Alegro with over 20 years of management experience, most
recently in the position of Managing Director of Shouldice Hospital, where he
was responsible for the financial leadership of the company. Prior to 2006,
Mr. Godard provided business advisory services to small and medium businesses,
specializing in strategic planning and sourcing conventional bank debt and
equity financing. He has held executive positions for Business Development
Bank of Canada, Manitoba Capital Fund, the Claims Network Inc, and Barclay's
Bank of Canada. Mr. Godard is a Chartered Accountant and received a Master of
Business Administration and a Bachelor of Commerce (Honours), both from the
University of Manitoba.

    About Alegro

    Alegro is a leading Canadian healthcare service provider. Through the
Company's subsidiaries - Don Mills Surgical Unit, Work Able Centres, Direct
Health Solutions and CanAm Research - Alegro provides a variety of surgical
procedures, disability management, third-party medical assessments and support
of drug trial administration. With a broad service offering, the growth of the
healthcare service sector and the establishment of AHP for expansion into new
healthcare sectors, Alegro is pursuing an integrated approach and an
aggressive acquisition strategy to become Canada's leading third-party
healthcare service provider. Alegro is listed on the TSX Venture Exchange
under the symbol AGO. For further information, please visit
www.alegrohealth.com.

    NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS
    RELEASE. THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE
    ADEQUACY OR ACCURACY OF THIS RELEASE.

    This press release contains "forward-looking statements" within the
meaning of applicable securities laws, such as statements concerning
anticipated future events, results, circumstances, performance or expectations
that are not historical facts. These statements are not guarantees of future
performance and are subject to numerous risks and uncertainties, including
those described in our regulatory filings. Those risks and uncertainties
include changes in the regulatory and competitive environments. Many of these
risks and uncertainties can affect our actual results and could cause our
actual results to differ materially from those expressed or implied in any
forward-looking statement made by us or on our behalf. All forward-looking
statements in this press release are qualified by these cautionary statements.
These statements are made as of the date of this press release and, except as
required by applicable law, we undertake no obligation to publicly update or
revise any forward-looking statement, whether as a result of new information,
future events or otherwise. Additionally, we undertake no obligation to
comment on analyses, expectations or statements made by third parties in
respect of Alegro, its financial or operating results or its securities.





For further information:

For further information: Brenda Rasmussen, President and CEO, Alegro
Health Corp, (416) 496-6166 x 328, brasmussen@alegrohealth.com; Michael Moore,
Investor Relations, Equicom Group, (416) 815-0700 x 241,
mmoore@equicomgroup.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890